NO905511D0 - Fremgangsmaate for fremstilling av 1-(4-fluorfenyl)-2-(4-((4-metansulfonamido- eller 4-acetamidofenyl)carbonyl)-1-piperidinyl)-etanon. - Google Patents

Fremgangsmaate for fremstilling av 1-(4-fluorfenyl)-2-(4-((4-metansulfonamido- eller 4-acetamidofenyl)carbonyl)-1-piperidinyl)-etanon.

Info

Publication number: NO905511D0
Authority: NO; Norway
Prior art keywords: metanesulphonamido; etanon; fluorphenyl; acetamidophenyl; piperidinyl
Prior art date: 1989-12-21

Application number

NO905511A

Other languages

English (en)

Other versions

NO176565B (no

NO176565C (no

NO905511L (no

Inventor

Albert Anthony Carr

Richard Cyrus Dage

John Ednar Koerner

Tung Li

Francis Peter Miller

Thaddeus Robert Nieduzak

Mark William Dudley

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-21

Filing date

1990-12-20

Publication date

1990-12-20

1990-12-20 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1990-12-20 Publication of NO905511D0 publication Critical patent/NO905511D0/no

1991-06-24 Publication of NO905511L publication Critical patent/NO905511L/no

1995-01-16 Publication of NO176565B publication Critical patent/NO176565B/no

1995-04-26 Publication of NO176565C publication Critical patent/NO176565C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Diabetes (AREA)
Anesthesiology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO905511A 1989-12-21 1990-12-20 Analogifremgangsmåte for fremstilling av antitrombotisk aktive forbindelser NO176565C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US45449789A	1989-12-21	1989-12-21
US60465190A	1990-11-01	1990-11-01

Publications (4)

Publication Number	Publication Date
NO905511D0 true NO905511D0 (no)	1990-12-20
NO905511L NO905511L (no)	1991-06-24
NO176565B NO176565B (no)	1995-01-16
NO176565C NO176565C (no)	1995-04-26

Family

ID=27037488

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO905511A NO176565C (no)	1989-12-21	1990-12-20	Analogifremgangsmåte for fremstilling av antitrombotisk aktive forbindelser

Country Status (20)

Country	Link
EP (1)	EP0437790B1 (no)
JP (1)	JP2934323B2 (no)
KR (1)	KR0184641B1 (no)
CN (1)	CN1025853C (no)
AR (1)	AR247200A1 (no)
AT (1)	ATE133163T1 (no)
AU (1)	AU635098B2 (no)
CA (1)	CA2032797C (no)
DE (1)	DE69024933T2 (no)
DK (1)	DK0437790T3 (no)
ES (1)	ES2084642T3 (no)
FI (1)	FI96946C (no)
GR (1)	GR3018895T3 (no)
HU (1)	HU210590B (no)
IE (1)	IE71039B1 (no)
IL (1)	IL96731A (no)
NO (1)	NO176565C (no)
NZ (1)	NZ236501A (no)
PT (1)	PT96291B (no)
TW (1)	TW199145B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5292752A (en) *	1989-12-21	1994-03-08	Merrell Dow Pharmaceuticals Inc.	Antithrombotic compounds
AU650031B2 (en) *	1990-06-07	1994-06-09	Aventisub Ii Inc.	1-Piperidinyl alkanoylarylsulfonamide derivatives
US5478846A (en) *	1990-06-07	1995-12-26	Merrell Dow Pharmaceuticals Inc.	1-piperidinyl alkanoylanyl sulfonamides for treatment of cardiac arrhythmia
EP0661266A1 (en) *	1993-12-27	1995-07-05	Toa Eiyo Ltd.	Substituted cyclic amine compounds as 5HT2 antagonists
JP3274579B2 (ja) *	1995-01-12	2002-04-15	住友製薬株式会社	脳血管障害に伴う精神症候治療剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4355037A (en) *	1981-11-12	1982-10-19	Hoechst-Roussel Pharmaceuticals	3-(4-Piperidyl)-1,2-benzisoxales
FR2581993B1 (fr) *	1985-05-14	1988-03-18	Synthelabo	Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
PH23283A (en) *	1986-02-26	1989-06-30	Eisai Co Ltd	Piperidine derivative, pharmaceutical composition containing the same and method of use thereof
EP0299955B1 (en) *	1987-01-12	1994-09-21	RICCHIO, Dominic A.	Method and apparatus for improved water massage
US5093341A (en) *	1987-12-17	1992-03-03	Merrell Dow Pharmaceuticals Inc.	N-aralkyl piperidine derivatives useful as antithrombolytic agents
US5064838A (en) *	1988-01-21	1991-11-12	Merrell Dow Pharmaceuticals	1,4-disubstituted-piperidinyl compounds as pain relievers
JP2969359B2 (ja) *	1989-01-13	1999-11-02	武田薬品工業株式会社	環状アミン化合物

1990
- 1990-12-17 NZ NZ236501A patent/NZ236501A/en unknown
- 1990-12-18 FI FI906246A patent/FI96946C/fi not_active IP Right Cessation
- 1990-12-18 TW TW079110633A patent/TW199145B/zh active
- 1990-12-18 AU AU68181/90A patent/AU635098B2/en not_active Ceased
- 1990-12-19 IL IL9673190A patent/IL96731A/en not_active IP Right Cessation
- 1990-12-19 JP JP2411705A patent/JP2934323B2/ja not_active Expired - Fee Related
- 1990-12-20 IE IE463290A patent/IE71039B1/en not_active IP Right Cessation
- 1990-12-20 KR KR1019900021184A patent/KR0184641B1/ko not_active Expired - Fee Related
- 1990-12-20 AT AT90124973T patent/ATE133163T1/de not_active IP Right Cessation
- 1990-12-20 DE DE69024933T patent/DE69024933T2/de not_active Expired - Fee Related
- 1990-12-20 ES ES90124973T patent/ES2084642T3/es not_active Expired - Lifetime
- 1990-12-20 CA CA002032797A patent/CA2032797C/en not_active Expired - Fee Related
- 1990-12-20 AR AR90318688A patent/AR247200A1/es active
- 1990-12-20 EP EP90124973A patent/EP0437790B1/en not_active Expired - Lifetime
- 1990-12-20 DK DK90124973.0T patent/DK0437790T3/da active
- 1990-12-20 CN CN90110137.0A patent/CN1025853C/zh not_active Expired - Fee Related
- 1990-12-20 NO NO905511A patent/NO176565C/no not_active IP Right Cessation
- 1990-12-20 PT PT96291A patent/PT96291B/pt not_active IP Right Cessation
- 1990-12-20 HU HU908370A patent/HU210590B/hu not_active IP Right Cessation
1996
- 1996-02-01 GR GR960400292T patent/GR3018895T3/el unknown

Also Published As

Publication number	Publication date
EP0437790A3 (en)	1992-04-08
ES2084642T3 (es)	1996-05-16
NZ236501A (en)	1992-12-23
DK0437790T3 (da)	1996-02-12
FI906246A0 (fi)	1990-12-18
FI96946C (fi)	1996-09-25
NO176565B (no)	1995-01-16
FI906246L (fi)	1991-06-22
GR3018895T3 (en)	1996-05-31
AU6818190A (en)	1991-06-27
DE69024933D1 (de)	1996-02-29
KR0184641B1 (ko)	1999-05-01
TW199145B (no)	1993-02-01
IE71039B1 (en)	1997-01-15
CN1025853C (zh)	1994-09-07
AR247200A1 (es)	1994-11-30
CA2032797C (en)	2002-03-19
FI96946B (fi)	1996-06-14
HU210590B (en)	1995-05-29
JP2934323B2 (ja)	1999-08-16
KR910011787A (ko)	1991-08-07
JPH04145068A (ja)	1992-05-19
HU908370D0 (en)	1991-07-29
EP0437790B1 (en)	1996-01-17
DE69024933T2 (de)	1996-05-30
IL96731A (en)	1995-06-29
ATE133163T1 (de)	1996-02-15
CA2032797A1 (en)	1991-06-22
EP0437790A2 (en)	1991-07-24
PT96291A (pt)	1991-09-30
AU635098B2 (en)	1993-03-11
PT96291B (pt)	1998-06-30
NO176565C (no)	1995-04-26
CN1052664A (zh)	1991-07-03
IE904632A1 (en)	1991-07-17
NO905511L (no)	1991-06-24

Publication	Publication Date	Title
FI905535A0 (fi)	1990-11-08	Foerfarande foer reproduktion av barrtraed genom somatisk embryogenes.
DK73193D0 (da)	1993-06-21	Substituerede 1-(4-piperidinyl)-2-(phenylethylpyridinyl)-methanoner
NO894086L (no)	1990-04-17	Fremgangsmaate for fremstilling av piperidinylbenzimidazoler.
NO894786L (no)	1990-06-05	Fremgangsmaate for fremstilling av propenonoksimetere.
NO900934L (no)	1990-08-29	Fremgangsmaate for fremstilling av nye derivater av 4-substituerte piperaziner.
NO885607D0 (no)	1988-12-16	Fremgangsmaate for fremstilling av piperidinylforbindelser.
NL950021I2 (nl)	1996-12-02	2-(Difluormethoxy)-1,1,1,2-tretrafluorethaan als anestheticum.
FI881404A7 (fi)	1988-09-26	Framstaellning av 4-/4-/4-/4-//2-(2,4 -difluorfenyl)-2-(1h-azolylmetyl)-1,3-dioxolan-4-yl/metoxi/fenyl/ -1-piperazinyl/fenyl/triazoloner.
FI911133L (fi)	1991-09-08	Derivat av 4-(aminometyl)piperidin, deras framstaellning och terapeutiska anvaendning.
NO902776L (no)	1990-12-27	Fremgangsmaate for fremstilling av nye acetylcholinesterase-inhibitorer.
ATE288918T1 (de)	2005-02-15	1-(4-(1-(4-fluorphenyl)-1h-indol-3-yl)1-butyl)- spiro-(isobenzofuran-1(3h),4'-piperidin)- hydrohalogenide
NL7804388A (nl)	1978-10-30	Nieuwe n-/1-(3-benzoylpropyl)-4-piperidyl/ sulfonzuur- amiden en werkwijze voor de bereiding daarvan.
NO155137C (no)	1987-02-18	Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av 2-(4-piperidyl)-1-(4-kinolyl)-etanon.
NO905511D0 (no)	1990-12-20	Fremgangsmaate for fremstilling av 1-(4-fluorfenyl)-2-(4-((4-metansulfonamido- eller 4-acetamidofenyl)carbonyl)-1-piperidinyl)-etanon.
FI914906A0 (fi)	1991-10-17	1-(3,4-dihydro-2-oxo-1h-kinolin-6-yl) -2-(4-(2-fenyletyl) piperidin-1-yl)etanol och -etanon, deras framstaellning och anvaendning inom terapi.
NO903513D0 (no)	1990-08-09	Fremgangsmaate for fremstilling av cykliske neurokinin a-antagonister.
IT1230798B (it)	1991-10-29	Procedimento di omologazione per preparare alcoli superiori.
JPS57122081A (en)	1982-07-29	Novel drug based on 1-(4-quinolyl)-2-(4- piperidyl)ethanol or 1-(4-quinolyl)-3-(4- piperidyl)-propanol derivative
FI955387L (fi)	1995-11-08	4(p-fluorifenyyli)-3-((3,4-(metyleenioksi)fenoksi)metyyli)-piperidiinin N-p-halobentsoyylimetyylijohdannaiset
DE3875543D1 (de)	1992-12-03	1-(2-(phenylmethyl)phenyl)-piperazin-verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
NO880337L (no)	1988-07-28	Fremgangsmaate for fremstilling av 3-aryl-5-alkylthio-4h-1,2,4-triazoler.
NO870891D0 (no)	1987-03-04	Fremgangsmaate for fremstilling av 4-(2-pyrimidinyl)-1-piperazinyl heterocykliske carbonyl-derivater.
IT8423808A0 (it)	1984-11-29	Procedimento per preparare 4-(2-fenossietil)-1,2,4-triazolone.
NO913720D0 (no)	1991-09-20	Fremgangsmaate for fremstilling av 1-((2s)-3-mercapto-methyl-1-oxopropyl)-l-prolin.
NO882861D0 (no)	1988-06-28	Fremgangsmaate for fremstilling av krystallinsk 2-(1-pentyl-3-guanidino) 4-(2-metyl-4-imidazolyl)-tiazol-dihydroklorid-trihydrat.

Legal Events

Date	Code	Title	Description
2001-08-13	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN JUNE 2001